Financial Data and Key Metrics Changes - Consolidated net sales revenue decreased by 10.4% compared to the prior year [13] - Underlying pretax income fell by 49.5% [13] - Underlying earnings per share declined by 47.4% [13] - The University of Michigan Consumer Sentiment Index dropped nearly 20 percentage points since the beginning of the year [12] - The company updated its full-year guidance to expect a low single-digit net sales revenue decline, a low single-digit underlying pretax income decline, and a low single-digit underlying earnings per share growth [13][50] Business Line Data and Key Metrics Changes - U.S. financial volume decreased by 15.7%, lagging behind U.S. brand volume, which was down 8.8% [14] - Net sales revenue per hectoliter in The Americas increased by 4.8% due to favorable net pricing growth and mix benefits [19] - EMEA and APAC financial volume decreased by 9.7% due to soft industry demand, but net sales revenue per hectoliter grew by 5.4% [19] Market Data and Key Metrics Changes - The beer industry faced significant macroeconomic pressures impacting consumer consumption behavior [7] - The competitive landscape in EMEA and APAC has intensified, with increased promotional intensity across channels [104] - The U.S. market is experiencing slower industry trends than expected, with a forecast of improvement in the latter half of the year [62][67] Company Strategy and Development Direction - The company is focusing on premiumizing its portfolio and strengthening core power brands [11][37] - Adjustments to capital expenditure plans are being made to prioritize high-growth initiatives while returning cash to shareholders [12][56] - The company aims to navigate short-term challenges while supporting long-term growth objectives [36][37] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the volatility in the global macroeconomic environment and its impact on consumer confidence and consumption trends [7][44] - The company remains committed to its long-term growth algorithm despite near-term challenges [11][37] - Management expressed confidence in the continued strengthening of core brands and the potential for future growth [10][21] Other Important Information - The company invested $88 million for an 8.5% equity stake in Fever Tree Drinks PLC and returned nearly $160 million to shareholders through dividends and share repurchases [20][43] - The company has executed over 40% of its share repurchase program within the first six quarters since its announcement [21][43] Q&A Session Summary Question: What has changed since the start of the year regarding the U.S. market? - Management indicated that the macroeconomic conditions were unexpected and have impacted consumer confidence and demand, leading to a slower industry performance than anticipated [62][64] Question: Are there concerns about losing market share? - Management confirmed that they have retained almost all of the share gained in 2023, with core brands showing strong performance and shelf space gains [72][73] Question: What are the expectations for the beer category growth? - Management noted that the softness in the industry is macro-driven and expects a return to more typical growth trends as the year progresses [100][101] Question: Can you elaborate on the competitive landscape in EMEA and APAC? - Management described the competitive pressures in the UK and Central and Eastern Europe, highlighting the need for a value-over-volume strategy and increased promotional activities [104][106]

Financial Performance - Net sales for Q1 2025 were $2,304.1 million, a decrease of 11.3% compared to $2,596.4 million in Q1 2024[19] - Gross profit for Q1 2025 was $850.9 million, down 11.7% from $963.5 million in Q1 2024[19] - Net income attributable to Molson Coors Beverage Company for Q1 2025 was $121.0 million, a decline of 41.8% from $207.8 million in Q1 2024[19] - Basic earnings per share for Q1 2025 were $0.60, compared to $0.98 in Q1 2024, reflecting a 38.8% decrease[19] - The company reported an income (loss) before income taxes of $156.3 million for the three months ended March 31, 2025, compared to $265.4 million for the same period in 2024[102] - Operating income decreased by 40.7% to $186.3 million for the three months ended March 31, 2025, compared to $314.3 million in the prior year[114] - The company reported a loss before income taxes of $44.2 million for the three months ended March 31, 2025, an increase of 74.5% compared to the prior year[142] - Income before income taxes declined by 34.7% for the three months ended March 31, 2025, primarily due to lower financial volumes and cost inflation related to materials and manufacturing expenses[136] Cash Flow and Liquidity - Cash and cash equivalents decreased to $412.7 million from $969.3 million at the end of 2024, a decline of 57.5%[23] - Net cash used in operating activities for Q1 2025 was $(90.7) million, compared to $25.4 million in Q1 2024[25] - The company reported a net positive cash position of $31.1 million from bank overdrafts and cash as of March 31, 2025, down from $46.0 million as of December 31, 2024[73] - Net cash used in investing activities increased to $341.3 million for the three months ended March 31, 2025, primarily due to investments in Fevertree Drinks plc and the acquisition of Fevertree USA, Inc.[151] Assets and Liabilities - Total assets as of March 31, 2025, were $25,930.5 million, slightly down from $26,064.3 million at the end of 2024[23] - Total liabilities decreased to $12,478.7 million as of March 31, 2025, from $12,611.6 million at the end of 2024[23] - As of March 31, 2025, total long-term debt was $6,154.6 million, an increase from $6,113.9 million as of December 31, 2024, reflecting a growth of approximately 0.67%[72] - Total current assets decreased to $1,601.7 million from $1,859.8 million as of December 31, 2024[174] - The total noncurrent assets increased slightly to $24,007.5 million from $23,958.2 million as of December 31, 2024[174] Shareholder Returns - The company paid dividends of $99.2 million in Q1 2025, slightly up from $96.8 million in Q1 2024[25] - The company declared dividends of $0.47 per share on February 12, 2025, compared to $0.44 per share declared during the same period in 2024[38] - The company repurchased a total of 1,036,630 shares of Class B common stock during the three months ended March 31, 2025, at an average price of $57.47 per share[191] - The total approximate dollar value of shares that may yet be purchased under the repurchase program is $1,151,367,074[191] - The Board approved a share repurchase program of up to $2.0 billion for Class B common stock, with an expected term of five years[191] Investments and Acquisitions - An investment of $88.1 million was made in Fevertree Drinks plc, aligning with the company's strategy to expand beyond the beer aisle[48] - The investment in Fevertree Drinks plc was recorded at a fair value of $113.8 million as of March 31, 2025, after an initial investment of $88.1 million[57] - The company obtained exclusive rights to produce, market, and sell Fever-Tree products in the U.S. effective February 1, 2025, aligning with its strategy to expand beyond the beer aisle[110] Market and Operational Insights - The company operates in two segments: the Americas and EMEA&APAC, with operations in various countries including the U.S., Canada, and several European and Asian markets[32] - Financial volume decreased by 14.3% to 15.409 million hectoliters for the three months ended March 31, 2025, compared to 17.974 million hectoliters in the prior year[114] - The Americas segment's net sales for the three months ended March 31, 2025, were $1,881.8 million, down from $2,145.4 million for the same period in 2024[102] - The Americas segment net sales decreased by 12.3% to $1,881.8 million for the three months ended March 31, 2025, compared to $2,145.4 million in the prior year[132] Compliance and Legal Matters - The company was in compliance with all debt covenants and financial ratios as of March 31, 2025[79] - The company has an accrued contingent liability of $9.8 million related to litigation and environmental issues, down from $71.1 million as of December 31, 2024[89] - The company paid $60.6 million on January 29, 2025, to resolve a trademark infringement lawsuit filed by Stone Brewing Company[90] Miscellaneous - The company recognized share-based compensation expense of $11.9 million for the three months ended March 31, 2025, compared to $12.8 million for the same period in 2024[43] - The effective tax rate for the three months ended March 31, 2025, remained flat at 21% compared to the prior year[87] - The company incurred $180.3 million in depreciation and amortization for the three months ended March 31, 2025[103]

Group 1: Earnings Performance - Molson Coors Brewing reported quarterly earnings of $0.50 per share, missing the Zacks Consensus Estimate of $0.80 per share, and down from $0.95 per share a year ago, representing an earnings surprise of -37.50% [1] - The company posted revenues of $2.3 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 5.51%, and down from $2.6 billion year-over-year [2] Group 2: Stock Performance and Outlook - Molson Coors shares have lost about 0.8% since the beginning of the year, while the S&P 500 has declined by -4.3% [3] - The current consensus EPS estimate for the coming quarter is $2.04 on revenues of $3.25 billion, and for the current fiscal year, it is $6.35 on revenues of $11.64 billion [7] Group 3: Industry Context - The Beverages - Alcohol industry, to which Molson Coors belongs, is currently in the bottom 42% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5]

FY 2025 RESULTS & OUTLOOK Q1 FORWARD LOOKING STATEMENTS & OTHER INFORMATION This presentation includes "forward-looking statements" within the meaning of the U.S. federal securities laws. Generally, the words "expects," "intend," "goals," "plans," "believes," "continues," "may," "anticipate," "seek," "estimate," "outlook," "trends," "future benefits," "potential," "projects," "strategies," "implies," and variations of such words and similar expressions are intended to identify forward-looking statements. St ...

Financial Performance - Net sales decreased by 11.3% to $2,304.1 million, with a 10.4% decline in constant currency[6] - U.S. GAAP income before income taxes fell by 41.1% to $156.3 million, while underlying income before income taxes decreased by 49.5% in constant currency to $131.1 million[6] - U.S. GAAP net income attributable to Molson Coors was $121.0 million, or $0.59 per diluted share, representing a 39.2% decline[6] - The Americas segment reported net sales of $1,881.8 million, down 12.3%, with financial volumes decreasing by 15.6%[13] - EMEA&APAC segment net sales decreased by 6.0% to $427.3 million, driven by a 9.7% decline in financial volumes[21] - Financial volumes decreased by 14.3%, primarily due to lower shipments in both the Americas and EMEA&APAC segments[11] - Financial and brand volumes decreased by 9.7% and 9.8%, respectively, due to lower volumes across all regions driven by soft market demand and heightened competition[23] - Net income for Q1 2025 was $123.1 million, down from $209.9 million in Q1 2024, representing a decrease of 41.3%[40] - Consolidated net sales for Q1 2025 were $2,304.1 million, a decline of 11.3% compared to $2,596.4 million in Q1 2024[41] - The Americas segment reported net sales of $1,881.8 million in Q1 2025, down 12.3% from $2,145.4 million in Q1 2024[41] - Total Worldwide Brand Volume decreased by 8.0% to 15.547 million hectoliters for the three months ended March 31, 2025, compared to 16.899 million hectoliters in the same period of 2024[45] Cash Flow and Debt - Net cash used in operating activities was $90.7 million for Q1 2025, compared to net cash provided of $25.4 million for Q1 2024, primarily due to lower net income adjusted for non-cash items[24] - Cash and cash equivalents decreased to $412.7 million at the end of Q1 2025 from $969.3 million at the beginning of the year, a decline of 57.5%[40] - The company experienced a net cash outflow from operating activities of $90.7 million in Q1 2025, compared to a cash inflow of $25.4 million in Q1 2024[40] - Total current liabilities decreased to $2,865.8 million as of March 31, 2025, from $3,045.2 million as of December 31, 2024, a reduction of 5.9%[39] - Total debt as of March 31, 2025, was $6,237.8 million, resulting in a net debt to underlying EBITDA ratio of 2.47x, up from 2.29x as of March 31, 2024[30] - As of March 31, 2025, the net debt stood at $5,825.1 million, slightly up from $5,759.3 million a year earlier[62] - The net debt to underlying EBITDA ratio increased to 2.47 as of March 31, 2025, compared to 2.29 in the previous year, indicating a higher leverage position[62] Guidance and Future Outlook - The company updated its 2025 full year guidance, projecting a low single-digit decline in net sales on a constant currency basis, compared to a previous expectation of low single-digit growth[6] - Capital expenditures for 2025 are now expected to be approximately $650 million, down from a previous estimate of $750 million[6] - The company adjusted its 2025 guidance due to impacts from the global macroeconomic environment on the beer industry and consumer trends[27] Operational Metrics - Gross profit for Q1 2025 was $850.9 million, down from $963.5 million in Q1 2024[38] - Underlying (Non-GAAP) free cash flow was $1.3 billion, plus or minus 10%[30] - The company's underlying income before income taxes for Q1 2025 was $131.1 million, down 49.3% from $258.8 million in Q1 2024[41] - The underlying EBITDA (Non-GAAP) for Q1 2025 was $353.3 million, down from $476.2 million in Q1 2024, marking a decline of approximately 26%[63] - U.S. GAAP depreciation and amortization for Q1 2025 was $180.3 million, up from $169.0 million in Q1 2024, reflecting increased asset depreciation[59] Investments and Partnerships - The company is focusing on premiumization initiatives and has formed an exclusive partnership with Fever-Tree to enhance its nonalcoholic operations[5] - The company made an investment in Fevertree Drinks plc, recording a gain of $25.7 million as an unrealized fair value adjustment[55] Tax and Other Adjustments - The effective tax rate remained flat at 21% compared to the prior year[12] - The company recorded total non-GAAP adjustment items of $(25.2) million for Q1 2025, compared to $(6.6) million in Q1 2024, indicating increased adjustments impacting financial results[56][57] - Accelerated depreciation of $17.9 million was recorded in Q1 2025 due to the decision to wind down certain U.S. craft businesses, impacting overall depreciation expenses[59]

Company Overview - Molson Coors Brewing (TAP) is headquartered in Golden and operates in the Consumer Staples sector [3] - The stock has experienced a price change of 0.21% since the beginning of the year [3] Dividend Information - Molson Coors currently pays a dividend of $0.47 per share, resulting in a dividend yield of 3.27% [3] - The Beverages - Alcohol industry's average yield is 0.49%, while the S&P 500's yield is 1.59% [3] - The company's annualized dividend of $1.88 has increased by 6.8% from the previous year [4] - Over the past five years, Molson Coors has raised its dividend four times, averaging an annual increase of 8.52% [4] - The current payout ratio is 29%, indicating that 29% of its trailing 12-month EPS has been distributed as dividends [4] Earnings Outlook - The Zacks Consensus Estimate for Molson Coors' earnings in 2025 is projected at $6.36 per share, reflecting an expected increase of 6.71% from the previous year [5] Investment Considerations - Dividends are favored by investors for various reasons, including improving stock investing profits and providing tax advantages [6] - Established firms with secure profits are typically viewed as the best dividend options, while high-growth businesses often do not offer dividends [7] - TAP is considered a compelling investment opportunity due to its strong dividend profile and a Zacks Rank of 3 (Hold) [7]

Core Viewpoint - Molson Coors Beverage Company (TAP) is anticipated to report declines in both revenue and earnings for the first quarter of 2025, with revenues expected at $2.4 billion, reflecting a 6% decrease year-over-year, and earnings per share projected at 80 cents, down 15.8% from the previous year [1] Financial Performance - In the last reported quarter, Molson Coors achieved an earnings surprise of 15%, with an average earnings surprise of 18.1% over the trailing four quarters [2] - The Zacks Model indicates a potential earnings beat for TAP, supported by a Zacks Rank of 3 (Hold) and an Earnings ESP of +4.01% [3] Market Trends and Growth Drivers - TAP has shown strong brand resilience, particularly in the U.S. market, with core brands like Coors Light and Miller Lite performing well, and Coors Banquet experiencing notable volume growth [4] - The company's Acceleration Plan has facilitated market share gains through innovation and premiumization, with strategic investments in core brands contributing to top-line growth [5] - Enhanced digital capabilities and expansion of brewing and packaging operations in the U.K. have been driven by the success of the Madri brand [6] - Strong performance in the EMEA and APAC segments, along with growth in Canada, has been supported by favorable net pricing and higher brand volumes [7] Challenges and Cost Pressures - The company faces challenges from inflationary pressures on raw materials and manufacturing costs, as well as an unfavorable product mix, which management has indicated will impact costs of goods sold (COGS) [8] - The evolving global macroeconomic environment, including geopolitical tensions and trade policy shifts, creates uncertainty that may affect consumer behavior and financial performance [9] - One-time transition and integration costs related to the partnership with Fever-Tree are expected to impact underlying financials for the first quarter [10] Valuation Perspective - Molson Coors is currently trading at a forward 12-month price-to-earnings ratio of 8.87X, which is below its five-year high of 15.57X and the industry average of 16.25X, indicating an attractive investment opportunity [12] - Over the past three months, TAP shares have increased by 5.9%, compared to the industry's growth of 17.4% [13]

Core Viewpoint - Analysts project that Molson Coors Brewing (TAP) will report quarterly earnings of $0.80 per share, reflecting a 15.8% decline year over year, with revenues expected to reach $2.44 billion, down 6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 0.3% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Forecast - Analysts estimate 'Net Sales- EMEA&APAC' at $451.89 million, a decrease of 0.6% from the prior-year quarter [5]. - 'Net Sales- Americas' is projected at $1.96 billion, reflecting an 8.7% decline from the same quarter last year [5]. - 'Brand Volume - Consolidated' is expected to reach 16.52 million, down from 16.9 million year-over-year [5]. Brand Volumes - 'Brand Volumes - Americas' is estimated at 12.42 million, compared to 12.89 million in the same quarter last year [6]. - 'Brand Volumes - EMEA&APAC' is projected at 3.82 million, down from 4.01 million in the same quarter last year [6]. Operating Income - The consensus for 'Operating income(loss)- Americas' is $271.60 million, a decrease from $320.60 million reported in the same quarter last year [7]. - Molson Coors shares have declined by 5.9% in the past month, contrasting with a 0.4% increase in the Zacks S&P 500 composite [7].

Molson Coors Brewing (TAP) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on May 8, 2025, might help the stock move higher if these key numbers are better than ...

Market Overview - Wall Street experienced significant losses, with the Dow recording back-to-back losses exceeding 1,500 points on April 3 and 4, including a drop of 2,231 points on April 4, marking one of the highest single-day declines in history [4] - The S&P 500 index fell more than 10% over the last two trading days of the previous week, with a 6% drop on April 6, its worst day since March 2020, currently in correction territory with a 17% decline from its February peak [5] - The Nasdaq Composite also plummeted 6% on each of the last two trading days, now in bear territory with a 22% drop from its recent high, while the CBOE VIX reached 45 on April 4, indicating extreme market fear [6] Defensive Stocks Recommendations - Investing in defensive sectors such as consumer staples, utilities, and healthcare is recommended, with five stocks identified: Molson Coors Beverage Co. (TAP), CenterPoint Energy Inc. (CNP), WEC Energy Group Inc. (WEC), Abbott Laboratories (ABT), and HCA Healthcare Inc. (HCA) [3][7] Company Insights Molson Coors Beverage Co. (TAP) - TAP has shown strong performance in Canada and EMEA&APAC, with Q4 2024 results surpassing estimates and year-over-year earnings growth [11] - Projected sales growth for 2025 is in low-single digits, with underlying EPS expected to grow in high-single digits [12] - Current revenue and earnings growth rates are 0.1% and 6.9%, respectively, with a dividend yield of 3.07% [13] CenterPoint Energy Inc. (CNP) - CNP is positioned to benefit from rising electricity demand due to the electrification of transportation and investments in renewable energy [14] - The company is investing in infrastructure to support electric vehicle (EV) growth, including off-road electrification initiatives [16] - Expected revenue and earnings growth rates for the current year are 3.2% and 8%, respectively, with a dividend yield of 2.44% [17] WEC Energy Group Inc. (WEC) - WEC is benefiting from both organic and inorganic growth, with strategic investments aimed at enhancing infrastructure and achieving net carbon neutrality by 2050 [18] - Demand from commercial and residential customers is improving, with expected revenue growth in the 2025-2027 period [19] - Current revenue and earnings growth rates are 9.2% and 8.5%, respectively, with a dividend yield of 3.42% [20] Abbott Laboratories (ABT) - ABT utilizes AI for healthcare solutions, including advanced medical imaging and predictive algorithms for heart attack prevention [21] - The company holds a strong position in point-of-care testing across various health areas [22] - Expected revenue and earnings growth rates for the current year are 5.9% and 10.3%, respectively, with a dividend yield of 1.90% [23] HCA Healthcare Inc. (HCA) - HCA's revenues are increasing due to growth in admissions and surgeries, with projected revenues for 2025 between $72.8 billion and $75.8 billion, indicating a 5.2% rise from 2024 [24] - The company has benefited from acquisitions and its telemedicine business, with operating cash flows rising 11.5% year over year in 2024 [25] - Expected revenue and earnings growth rates for the current year are 5.8% and 13.8%, respectively, with a dividend yield of 0.87% [25]